Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၁.၄၁%
၁,၀၇၆.၁၃
-၁၅.၃၈
-၁.၄၁%
—၁,၀၉၁.၅၁၁,၀၉၀.၄၀၁,၀၉၀.၄၀၁,၀၇၃.၆၉——
SIXC
Communications
SIXC
Communications
SIXC
-၀.၅၅%
၆၀၆.၇၄
-၃.၃၇
-၀.၅၅%
—၆၁၀.၁၁၆၁၀.၁၁၆၁၀.၂၉၆၀၆.၁၇——
SIXE
Energy
SIXE
Energy
SIXE
+၀.၈၈%
၁,၂၄၈.၈၂
+၁၀.၈၄
+၀.၈၈%
—၁,၂၃၇.၉၈၁,၂၃၇.၈၃၁,၂၅၂.၄၁၁,၂၂၅.၀၃——
SIXI
Industrials
SIXI
Industrials
SIXI
-၁.၁၇%
၁,၇၂၄.၃၆
-၂၀.၃၅
-၁.၁၇%
—၁,၇၄၄.၇၁၁,၇၄၀.၉၅၁,၇၄၇.၂၉၁,၇၂၁.၅၇——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၇၂%
၆၃၅.၅၉
-၄.၅၉
-၀.၇၂%
—၆၄၀.၁၈၆၃၉.၉၂၆၄၃.၁၉၆၃၄.၇၃——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၇၆%
၈၄၃.၁၅
-၆.၄၃
-၀.၇၆%
—၈၄၉.၅၈၈၄၅.၂၇၈၅၁.၆၈၈၃၉.၄၇——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၅၅%
၂၁၆.၂၉
-၁.၁၉
-၀.၅၅%
—၂၁၇.၄၈၂၁၇.၄၈၂၁၈.၁၆၂၁၅.၅၁——
SIXT
Technology
SIXT
Technology
SIXT
+၀.၀၈%
၃,၂၆၃.၄၁
+၂.၇၂
+၀.၀၈%
—၃,၂၆၀.၆၉၃,၂၇၃.၃၆၃,၂၈၇.၈၁၃,၂၄၀.၇၈——
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၃၄%
၉၃၉.၂၄
-၃.၂၁
-၀.၃၄%
—၉၄၂.၄၅၉၃၉.၃၉၉၄၈.၈၀၉၃၃.၉၈——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၂၉%
၁,၄၆၂.၅၆
-၄.၂၄
-၀.၂၉%
—၁,၄၆၆.၈၀၁,၄၆၄.၇၀၁,၄၆၇.၁၉၁,၄၅၈.၃၆——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-၀.၇၁%
၂,၃၈၀.၄၀
-၁၇.၁၀
-၀.၇၁%
—၂,၃၉၇.၅၀၂,၃၉၅.၀၃၂,၄၁၂.၀၁၂,၃၇၀.၆၄——
INCY:NASDAQ
Incyte Corp
၉၇.၁၄ US$
+၀.၂၄%
(+၀.၂၃) 1D
၉၇.၁၄ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: မေ ၄, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INCY...
Open
၉၆.၅၄ US$
High
၉၇.၆၀ US$
Low
၉၆.၃၄ US$
Mkt. cap
ဋေ ၁.၉၄ ထ
Avg. vol.
၁.၅၄ သန်း
Volume
၁.၀၂ သန်း
P/E ratio
၁၃.၇၃
52-wk high
၁၁၂.၂၉ US$
52-wk low
၅၇.၇၇ US$
EPS
၇.၀၇ US$
Beta
၀.၇၉
Shares outstanding
၁၉.၉၈ ကုဋေ
No. of employees
၃ ထောင်
News stories
From sources across the web
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၁၃ နာရီ
Incyte (INCY) Partners with MacroGenics in Expanded Royalty Agre
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
Incyte (INCY) Positioned to Offset Patent Cliff Risks, Analysts Reaffirm Stock Ratings
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၂ ရက်
Is It Too Late To Consider Incyte (INCY) After A 55% One Year Rally?
Investing.com Nigeria
Investing.com Nigeria
·
ပြီးခဲ့သည့် ၂ ရက်
FDA approves Incyte’s once-daily Jakafi XR formulation By Investing.com
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEOHervé Hoppenot
Employees၂.၈၄ ထောင်
Founded၂၀၀၂
HeadquartersWilmington, ဒယ်လာဝဲပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteincyte.com
Last report
၂၀၂၆ ဧ ၂၈
Fiscal Period
Q1 2026
Normalized EPS / Estimate
၁.၈၁/ (၁.၃၄ est.)USD
+၃၅.၁၂%beat
Revenue / Estimate
၁၂၇.၂၇ ဋေ/ (၁၂၁.၁၃ ဋေ est.)USD
+၅.၀၇%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၁၂၁.၅၅ ဋေ
၁၃၆.၆၀ ဋေ
၁၅၀.၆၈ ဋေ
၁၂၇.၂၇ ဋေ
Cost of goods sold
၅၇.၃၇ ကုဋေ
၆၀.၅၆ ကုဋေ
၇၃.၂၅ ကုဋေ
၆၂.၀၄ ကုဋေ
Cost of revenue
၅၇.၃၇ ကုဋေ
၆၀.၅၆ ကုဋေ
၇၃.၂၅ ကုဋေ
၆၂.၀၄ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၃.၀၃ ကုဋေ
၃၂.၈၃ ကုဋေ
၃၈.၉၀ ကုဋေ
၃၂.၇၁ ကုဋေ
Operating expense
၃၃.၀၃ ကုဋေ
၃၂.၈၃ ကုဋေ
၃၈.၉၀ ကုဋေ
၃၂.၇၁ ကုဋေ
Total operating expenses
၉၀.၃၉ ကုဋေ
၉၃.၃၉ ကုဋေ
၁၁၂.၁၅ ဋေ
၉၄.၇၅ ကုဋေ
Operating income
၃၁.၁၆ ကုဋေ
၄၃.၂၁ ကုဋေ
၃၈.၅၃ ကုဋေ
၃၂.၅၂ ကုဋေ
Other non operating income
၆.၅၄ သန်း
၃.၂၅ သန်း
၄.၂၂ သန်း
၁.၇၅ သန်း
EBT including unusual items
၅၅.၈၀ ကုဋေ
၄၈.၂၃ ကုဋေ
၃၈.၉၉ ကုဋေ
၃၄.၃၆ ကုဋေ
EBT excluding unusual items
၃၄.၂၇ ကုဋေ
၄၆.၁၅ ကုဋေ
၄၁.၉၇ ကုဋေ
၃၆.၀၁ ကုဋေ
Income tax expense
၁၅.၃၀ ကုဋေ
၅.၈၁ ကုဋေ
၉.၀၇ ကုဋေ
၄.၀၃ ကုဋေ
Effective tax rate
၂၇.၄၂%
၁၂.၀၅%
၂၃.၂၅%
၁၁.၇၂%
Other operating expenses
-
-
-
-
Net income
၄၀.၅၀ ကုဋေ
၄၂.၄၂ ကုဋေ
၂၉.၉၃ ကုဋေ
၃၀.၃၃ ကုဋေ
Net profit margin
၃၃.၃၂%
၃၁.၀၅%
၁၉.၈၆%
၂၃.၈၃%
Earnings per share
၁.၅၇
၂.၂၆
၁.၈၀
၁.၈၁
Interest and investment income
၂.၅၁ ကုဋေ
၂.၆၈ ကုဋေ
၃.၀၈ ကုဋေ
၃.၃၇ ကုဋေ
Interest expense
-၅.၉၄ သိန်း
-၅.၉၂ သိန်း
-၅.၈၂ သိန်း
-၅.၆၉ သိန်း
Net interest expenses
၂.၄၅ ကုဋေ
၂.၆၂ ကုဋေ
၃.၀၂ ကုဋေ
၃.၃၁ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၃၃.၄၅ ကုဋေ
၄၅.၆၁ ကုဋေ
၄၀.၉၃ ကုဋေ
၃၄.၉၀ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer